Clinical Trial Update: RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections. [Phase 1]

View source ↗

Summary

Phase 1 trial of the RSV001 vaccine to prevent severe respiratory syncytial virus infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV001

Snippet

Sponsor: ReiThera Srl | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: COMPLETED